Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.35
0.00 (0.00%)
Oct 9, 2025, 4:00 PM EDT - Market closed

TDAC Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2024
Period Ending
Dec '24 Dec '23
Selling, General & Admin
0.20.49
Total Operating Expenses
0.20.49
Operating Income
-0.2-0.49
Interest Income
0.13-
Total Non-Operating Income (Expense)
0.13-
Pretax Income
-0.07-0.49
Net Income
-0.07-0.49
Net Income to Common
-0.07-0.49
Shares Outstanding (Basic)
0-
Shares Outstanding (Diluted)
0-
EPS (Basic)
-0.02-
EPS (Diluted)
-0.01-
Free Cash Flow
-0.85-0
Free Cash Flow Per Share
-2.57-
EBITDA
-0.2-0.49
EBIT
-0.2-0.49
Updated Dec 31, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q